Previous studies have also shown higher levels of PPARGC1α DNA methylation in samples from type 2 diabetes (T2D) compared to NGT subjects when quantified in human pancreatic islets, muscle, and subcutaneous adipose tissue (SAT) biopsies [36–38, 47]. This evidence concerns the gene PPARGC1A and type 2 diabetes mellitus.